Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOST | Q9BQB4 | 1/20 | 0.72 |
| ▸ | GART | P22102 | 6/20 | 0.70 |
| ▸ | FPGS | Q05932 | 2/20 | 0.64 |
| ▸ | DHFR | P00374 | 3/20 | 0.59 |
| ▸ | ATIC | P31939 | 4/20 | 0.55 |
| ▸ | TYMS | P04818 | 1/20 | 0.55 |
| ▸ | MTHFD2 | P13995 | 2/20 | 0.54 |
| ▸ | MTHFD1 | P11586 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12704421 | 1.00 | SOST (0.72) | SOSTGARTFPGSDHFRATIC | |
| SCHEMBL258465 | 1.00 | SOST (0.72) | SOSTGARTFPGSDHFRATIC | |
| SCHEMBL8061 | 1.00 | SOST (0.72) | SOSTGARTFPGSDHFRATIC | |
| SCHEMBL8060 | 1.00 | SOST (0.72) | SOSTGARTFPGSDHFRATIC | |
| SCHEMBL29616598 | 1.00 | SOST (0.72) | SOSTGARTFPGSDHFRATIC | |
| SCHEMBL13418310 | 1.00 | SOST (0.72) | SOSTGARTFPGSDHFRATIC | |
| SCHEMBL5829838 | 0.96 | SOST (0.66) | SOSTGARTFPGSDHFRATIC | |
| Tetrahydrofolate SCHEMBL18703989 | 0.94 | SOST (0.82) | SOSTGARTFPGSDHFRATIC | |
| SCHEMBL11475679 | 0.93 | SOST (0.62) | SOSTGARTFPGSDHFRATIC | |
| SCHEMBL8160135 | 0.93 | SOST (0.71) | SOSTGARTFPGSDHFRATIC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6808725-B2 | FOOD ADDITIVE | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION | 2004-10-26 | — | — | US | claimed |
| EP-1425978-A1 | Food and vitamin preparations containing the natural isomer of reduced folates | South Alabama Medical Science Foundation (US) | 2004-06-09 | — | — | EP | claimed |
| EP-0877563-B1 | FOOD AND VITAMIN PREPARATIONS CONTAINING THE NATURAL ISOMER OF REDUCED FOLATES | UNIV SOUTH ALABAMA (US) | 2004-03-31 | — | — | EP | claimed |
| US-20020176912-A1 | Food and vitamin preparations containing the natural isomer of reduced folates | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION | 2002-11-28 | — | — | US | claimed |
| US-20020150653-A1 | Food and vitamin preparations containing the natural isomer of reduced folates | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION | 2002-10-17 | — | — | US | claimed |
| US-20010046533-A1 | METHOD FOR TREATING A SUBJECT AFFLICTED WITH INTESTINAL MALABSORPTION | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION | 2001-11-29 | — | — | US | claimed |
| US-5997915-A | NATURAL ISOMERS OF TETRAHYDROFOLIC ACID DERIVATIVES | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION (US) | 1999-12-07 | — | — | US | claimed |
| EP-0877563-A4 | FOOD AND VITAMIN PREPARATIONS CONTAINING THE NATURAL ISOMER OF REDUCED FOLATES | UNIV SOUTH ALABAMA (US) | 1999-06-09 | — | — | EP | claimed |
| EP-0877563-A1 | FOOD AND VITAMIN PREPARATIONS CONTAINING THE NATURAL ISOMER OF REDUCED FOLATES | South Alabama Medical Science Foundation (US) | 1998-11-18 | — | — | EP | claimed |
| WO-1997027764-A1 | FOOD AND VITAMIN PREPARATIONS CONTAINING THE NATURAL ISOMER OF REDUCED FOLATES | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION (US) | 1997-08-07 | — | — | WO | claimed |
| JP-11116482-A | — | — | None | — | — | JP | disclosed |
| EP-2773355-B1 | METHODS, FORMULATIONS, AND KITS FOR RAPIDLY REPLETING FOLATE LEVELS IN WOMEN | SOUTH ALABAMA MEDICAL SCIENCE FOUND (US) | 2022-06-08 | — | — | EP | disclosed |
| US-10357496-B2 | Methods, formulations, and kits for rapidly repleting folate levels in women | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION (US) | 2019-07-23 | — | — | US | disclosed |
| US-9895328-B2 | Calcium formate as a supplement to prevent neural tube defects | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2018-02-20 | — | — | US | disclosed |
| US-20160193164-A1 | CALCIUM FORMATE AS A SUPPLEMENT TO PREVENT NEURAL TUBE DEFECTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2016-07-07 | — | — | US | disclosed |
| US-5997915-A | NATURAL ISOMERS OF TETRAHYDROFOLIC ACID DERIVATIVES | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION (US) | 1999-12-07 | — | — | US | disclosed |
| EP-0877563-A4 | FOOD AND VITAMIN PREPARATIONS CONTAINING THE NATURAL ISOMER OF REDUCED FOLATES | UNIV SOUTH ALABAMA (US) | 1999-06-09 | — | — | EP | disclosed |
| JP-H11116482-A | USAGE OF TETRAHYDROFOLATE OF NATURAL STEROISOMERIC FORM IN PRODUCTION OF AGENT SUITABLE FOR EXERTING INFLUENCE ON HOMOCYSTENINE-LEVEL, ESPECIALLY SUITABLE FOR ASSISTING REMETHYLATION OF HOMOCYSTENINE | EPROVA AG | 1999-04-27 | — | — | JP | disclosed |
| EP-0877563-A1 | FOOD AND VITAMIN PREPARATIONS CONTAINING THE NATURAL ISOMER OF REDUCED FOLATES | South Alabama Medical Science Foundation (US) | 1998-11-18 | — | — | EP | disclosed |
| WO-1997027764-A1 | FOOD AND VITAMIN PREPARATIONS CONTAINING THE NATURAL ISOMER OF REDUCED FOLATES | SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION (US) | 1997-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160193164-A1 | CALCIUM FORMATE AS A SUPPLEMENT TO PREVENT NEURAL TUBE DEFECTS | SLC19A1, FOLR2, SLC46A1 | SOST 1449/4885GART 180/4885FPGS 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.